Delivery Order SPE2DB20D1100-SPE2DB24FB1J9
Award Date
4/5/24
Potential Completion Date
4/8/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,393.65, is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,166.32, is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 26, 2023. This order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,211.10, is a delivery order for the medication KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The contract has an ultimate completion date of November 29, 2024 and is a firm fixed-price arrangement. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,551.68, is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a medical product. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor. The contract is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The contract, valued at $2,532.72, is a firm fixed-price delivery order with an ultimate completion date of August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order is part of a...
Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract worth $9,294.58 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
This is a $9,480.42 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a period of performance through March 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,233.05, is a delivery order under a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.39, is a Firm Fixed Price Delivery Order for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a performance period through March 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,375.40, is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 17, 2023. There is no set-aside designation for this contract. Amerisourcebergen holds a large Indefinite Delivery...